Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 1
1971 1
1976 1
1977 3
1979 1
1980 2
1981 1
1982 2
1983 1
1985 3
1986 2
1987 1
1989 7
1990 7
1991 2
1992 3
1993 3
1994 2
1995 2
1996 5
1997 3
1998 5
1999 7
2000 4
2001 1
2002 5
2003 7
2004 4
2005 3
2006 5
2007 8
2008 4
2009 6
2010 5
2011 9
2012 8
2013 7
2014 2
2015 3
2016 7
2017 8
2018 5
2019 6
2020 4
2021 8
2022 14
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
AIRO Breast Cancer Group Best Clinical Practice 2022 Update.
Ciabattoni A, Gregucci F, De Rose F, Falivene S, Fozza A, Daidone A, Morra A, Smaniotto D, Barbara R, Lozza L, Vidali C, Borghesi S, Palumbo I, Huscher A, Perrucci E, Baldissera A, Tolento G, Rovea P, Franco P, De Santis MC, Grazia AD, Marino L, Meduri B, Cucciarelli F, Aristei C, Bertoni F, Guenzi M, Leonardi MC, Livi L, Nardone L, De Felice F, Rosetto ME, Mazzuoli L, Anselmo P, Arcidiacono F, Barbarino R, Martinetti M, Pasinetti N, Desideri I, Marazzi F, Ivaldi G, Bonzano E, Cavallari M, Cerreta V, Fusco V, Sarno L, Bonanni A, Mangiacotti MG, Prisco A, Buonfrate G, Andrulli D, Fontana A, Bagnoli R, Marinelli L, Reverberi C, Scalabrino G, Corazzi F, Doino D, Di Genesio-Pagliuca M, Lazzari M, Mascioni F, Pace MP, Mazza M, Vitucci P, Spera A, Macchia G, Boccardi M, Evangelista G, Sola B, La Porta MR, Fiorentino A, Levra NG, Ippolito E, Silipigni S, Osti MF, Mignogna M, Alessandro M, Ursini LA, Nuzzo M, Meattini I, D'Ermo G. Ciabattoni A, et al. Tumori. 2022 Jul;108(2_suppl):1-144. doi: 10.1177/03008916221088885. Tumori. 2022. PMID: 36112842
INTRODUCTION: Breast cancer is the most common tumor in women and represents the leading cause of cancer death. Radiation therapy plays a key-role in the treatment of all breast cancer stages. ...In recent years, the high-level quality radiation therapy has shown a …
INTRODUCTION: Breast cancer is the most common tumor in women and represents the leading cause of cancer death. Radiation therapy pla …
Management of borderline ovarian tumours.
Gershenson DM. Gershenson DM. Best Pract Res Clin Obstet Gynaecol. 2017 May;41:49-59. doi: 10.1016/j.bpobgyn.2016.09.012. Epub 2016 Oct 3. Best Pract Res Clin Obstet Gynaecol. 2017. PMID: 27780698 Review.
Prognostic factors include the International Federation of Gynecology and Obstetrics (FIGO) stage, presence of peritoneal implants, micropapillary pattern (for serous histology), microinvasion and intra-epithelial carcinoma (for mucinous histology). ...However, because the …
Prognostic factors include the International Federation of Gynecology and Obstetrics (FIGO) stage, presence of peritoneal implants, micropap …
Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.
Hauptmann S, Friedrich K, Redline R, Avril S. Hauptmann S, et al. Virchows Arch. 2017 Feb;470(2):125-142. doi: 10.1007/s00428-016-2040-8. Epub 2016 Dec 27. Virchows Arch. 2017. PMID: 28025670 Free PMC article. Review.
Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms, intermediate between benign and malignant categories. Since BOT were first identified >40 years ago, they have inspired controversies disproportionate to their incidence. ...T …
Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms, intermediate between benign and malignant …
Cervical Cancer: Evaluation and Management.
Wipperman J, Neil T, Williams T. Wipperman J, et al. Am Fam Physician. 2018 Apr 1;97(7):449-454. Am Fam Physician. 2018. PMID: 29671552 Free article.
Once cervical cancer is diagnosed, treatment may involve surgery, radiation therapy, chemotherapy, or a combination. The choice of therapy depends on the stage of disease, lymph node involvement, patient comorbidities, and risk factors for recurrence. Early-stage, …
Once cervical cancer is diagnosed, treatment may involve surgery, radiation therapy, chemotherapy, or a combination. The choice of …
Management of stage I and II cervical cancer: a review.
Chou B, Prasad Venkatesulu B, Coleman RL, Harkenrider M, Small W Jr. Chou B, et al. Int J Gynecol Cancer. 2022 Mar;32(3):216-224. doi: 10.1136/ijgc-2021-002527. Int J Gynecol Cancer. 2022. PMID: 35256406 Review.
Multiple specialists including gynecologic oncologists, radiation oncologists, medical oncologists, radiologists, pathologists, and other ancillary staff, often with subspecialty experience in gynecology or cancer care, now staff multidisciplinary gynecologic oncology team …
Multiple specialists including gynecologic oncologists, radiation oncologists, medical oncologists, radiologists, pathologists, and other an …
Hepatic Cysts: Reappraisal of the Classification, Terminology, Differential Diagnosis, and Clinicopathologic Characteristics in 258 Cases.
Armutlu A, Quigley B, Choi H, Basturk O, Akkas G, Pehlivanoglu B, Memis B, Jang KT, Erkan M, Erkan B, Balci S, Saka B, Bagci P, Farris AB, Kooby DA, Martin D, Kalb B, Maithel SK, Sarmiento J, Reid MD, Adsay NV. Armutlu A, et al. Am J Surg Pathol. 2022 Sep 1;46(9):1219-1233. doi: 10.1097/PAS.0000000000001930. Epub 2022 Jul 4. Am J Surg Pathol. 2022. PMID: 35778790
Neoplastic (13%); 27 (10.5%) had ovarian-type stroma (OTS) and qualified as mucinous cystic neoplasm (MCN) per World Health Organization (WHO). These were female, solitary, mean age 52, mean size 11 cm, and 2 were associated with carcinoma (1 in situ and 1 microinvasive …
Neoplastic (13%); 27 (10.5%) had ovarian-type stroma (OTS) and qualified as mucinous cystic neoplasm (MCN) per World Health Organizat …
Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management.
Ricotta G, Maulard A, Candiani M, Genestie C, Pautier P, Leary A, Chargari C, Mangili G, Morice P, Gouy S. Ricotta G, et al. Ann Surg Oncol. 2022 Feb;29(2):1165-1170. doi: 10.1245/s10434-021-10776-7. Epub 2021 Oct 1. Ann Surg Oncol. 2022. PMID: 34596794
One patient had bilateral tumor, and all cases were stage-I disease. All CCBOTs showed an adenofibromatous pattern. Stromal microinvasion was observed in seven cases and intraepithelial carcinoma in two cases. ...
One patient had bilateral tumor, and all cases were stage-I disease. All CCBOTs showed an adenofibromatous pattern. Stromal microinvasion …
ACR Appropriateness Criteria Ductal Carcinoma in Situ.
Kaufman SA, Harris EE, Bailey L, Chadha M, Dutton SC, Freedman GM, Goyal S, Halyard MY, Horst KC, Novick KL, Park CC, Suh WW, Toppmeyer D, Zook J, Haffty BG. Kaufman SA, et al. Oncology (Williston Park). 2015 Jun;29(6):446-58, 460-1. Oncology (Williston Park). 2015. PMID: 26089220 Free article. Review.
Ductal carcinoma in situ (DCIS) is a breast neoplasm with potential for progression to invasive cancer. Management commonly involves excision, radiotherapy, and hormonal therapy. Surgical assessment of regional lymph nodes is rarely indicated except in cases of m …
Ductal carcinoma in situ (DCIS) is a breast neoplasm with potential for progression to invasive cancer. Management commonly involves …
Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature.
Bisseling KC, Bekkers RL, Rome RM, Quinn MA. Bisseling KC, et al. Gynecol Oncol. 2007 Dec;107(3):424-30. doi: 10.1016/j.ygyno.2007.07.062. Epub 2007 Aug 20. Gynecol Oncol. 2007. PMID: 17707895 Review.
OBJECTIVE: To investigate the efficacy of different treatment modalities used in microinvasive adenocarcinoma (AC) of the uterine cervix (FIGO stage IA1 and IA2), and review the literature. METHODS: Medical and histopathological records of 38 patients treated for microi …
OBJECTIVE: To investigate the efficacy of different treatment modalities used in microinvasive adenocarcinoma (AC) of the uterine cer …
185 results